These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2573737)

  • 1. The translational requirement for complete La Crosse virus mRNA synthesis is cell-type dependent.
    Raju R; Raju L; Kolakofsky D
    J Virol; 1989 Dec; 63(12):5159-65. PubMed ID: 2573737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translational requirement for La Crosse virus S-mRNA synthesis: a possible mechanism.
    Bellocq C; Kolakofsky D
    J Virol; 1987 Dec; 61(12):3960-7. PubMed ID: 3682062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The translational requirement for La Crosse virus S-mRNA synthesis.
    Kolakofsky D; Bellocq C; Raju R
    Cold Spring Harb Symp Quant Biol; 1987; 52():373-9. PubMed ID: 3454266
    [No Abstract]   [Full Text] [Related]  

  • 4. La Crosse virus small genome mRNA is made in the cytoplasm.
    Rossier C; Patterson J; Kolakofsky D
    J Virol; 1986 May; 58(2):647-50. PubMed ID: 3701924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. La Crosse virions contain a primer-stimulated RNA polymerase and a methylated cap-dependent endonuclease.
    Patterson JL; Holloway B; Kolakofsky D
    J Virol; 1984 Oct; 52(1):215-22. PubMed ID: 6481853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of protein synthesis inhibit both La Crosse virus S-mRNA and S genome syntheses in vivo.
    Raju R; Kolakofsky D
    Virus Res; 1986 Jul; 5(1):1-9. PubMed ID: 3751285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational requirement of La Crosse virus S-mRNA synthesis: in vitro studies.
    Bellocq C; Raju R; Patterson J; Kolakofsky D
    J Virol; 1987 Jan; 61(1):87-95. PubMed ID: 3783826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of La Crosse virus small-genome transcripts.
    Patterson JL; Kolakofsky D
    J Virol; 1984 Mar; 49(3):680-5. PubMed ID: 6321757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. La Crosse virus nucleocapsid protein controls its own synthesis in mosquito cells by encapsidating its mRNA.
    Hacker D; Raju R; Kolakofsky D
    J Virol; 1989 Dec; 63(12):5166-74. PubMed ID: 2573738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LaCrosse virus gene expression in mammalian and mosquito cells.
    Rossier C; Raju R; Kolakofsky D
    Virology; 1988 Aug; 165(2):539-48. PubMed ID: 2900578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning and sequencing of the La Crosse virus S RNA.
    Cabradilla CD; Holloway BP; Obijeski JF
    Virology; 1983 Jul; 128(2):463-8. PubMed ID: 6684362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple leader RNAs and messenger RNAs are transcribed from the La Crosse virus small genome segment.
    Patterson JL; Cabradilla C; Holloway BP; Obijeski JF; Kolakofsky D
    Cell; 1983 Jul; 33(3):791-9. PubMed ID: 6871993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual transcripts in La Crosse virus-infected cells and the site for nucleocapsid assembly.
    Raju R; Kolakofsky D
    J Virol; 1987 Mar; 61(3):667-72. PubMed ID: 3806796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyses of the 3'-terminal sequences of snowshoe hare and La Crosse Bunyaviruses.
    Haaster CC; Bishop DH
    Virology; 1980 Sep; 105(2):564-74. PubMed ID: 7423860
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic determinants of the virulence and infectivity of La Crosse virus.
    Gonzalez-Scarano F; Beaty B; Sundin D; Janssen R; Endres MJ; Nathanson N
    Microb Pathog; 1988 Jan; 4(1):1-7. PubMed ID: 3059135
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional L polymerase of La Crosse virus allows in vivo reconstitution of recombinant nucleocapsids.
    Blakqori G; Kochs G; Haller O; Weber F
    J Gen Virol; 2003 May; 84(Pt 5):1207-1214. PubMed ID: 12692286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme processing of La Crosse virus glycoprotein G1: a bunyavirus-vector infection model.
    Ludwig GV; Christensen BM; Yuill TM; Schultz KT
    Virology; 1989 Jul; 171(1):108-13. PubMed ID: 2662577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome sequence analysis of La Crosse virus and in vitro and in vivo phenotypes.
    Bennett RS; Ton DR; Hanson CT; Murphy BR; Whitehead SS
    Virol J; 2007 May; 4():41. PubMed ID: 17488515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of La Crosse virus replication by monensin, monovalent ionophore.
    Cash P
    J Gen Virol; 1982 Mar; 59(Pt 1):193-6. PubMed ID: 7069403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of the ends of La Crosse virus small RNA as a double-stranded structure.
    Patterson JL; Kolakofsky D; Holloway BP; Obijeski JF
    J Virol; 1983 Feb; 45(2):882-4. PubMed ID: 6834474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.